CLOV - February 7, 2021
CLOV was bought out from a Chamath SPAC, this ticker has been in the headlines recently for investigation by the SEC for upping prices for healthcare services. Look for Chamath tweets and news on the stock to produce movement. From a technical standpoint, if we see a breakout look for resistance around 14.30 and 18 before moving higher with a 6-week price target of 24. Support is around 11.30, invalidation occurs around 12.20. CLOV has earnings coming up on February 25th, 2021 pre-market.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.